UK Pharmaceutical Research to be honoured

Fourteen entries will be vying for the prestigious 2006 UK Prix Galien Award it was announced today. The entries are:

• Alvesco - Altana Pharma (Respiratory)
• Alimta - Eli Lilly and Company (Oncology)
• Myozyme - Genzyme Speciality Therapeutics (Metabolic disorders)
• Rotarix - GlaxoSmithKline (Gastroenterology)
• Erbitux - Merck Pharmaceuticals (Oncology)
• Moviprep - Norgine (Gastroenterology)
• Movicol Paediatric (Gastroenterology)
• Xolair - Novartis (Respiratory)
• Aromasin - Pfizer (Oncology)
• Lyrica - Pfizer (Neurology)
• Avastin - Roche (Oncology)
• Tarceva - Roche (Oncology)
• Zevalin - Schering Healthcare (Oncology)
• Protelos - Servier Laboratories (Endocrine system)

The award recognises outstanding achievement in pharmaceutical research and development, and is presented to the most innovative treatment to have been recently developed in the UK.

The independent judging committee members currently range from experts within the National Institute of Clinical Excellence (NICE) and the Scottish Medicines Consortium (SMC) through to leading medical consultants, academics and a media doctor.

When deciding upon the winners they have been asked to identify the medicines that have made the most significant contribution to patient care in the UK. They also judge against broader themes such as efficacy, safety, benefits and innovation.

The overall winning entry will receive the gold Prix Galien medal. Previous winners of this highly prestigious honour are Herceptin, Prevenar and Viagra.

The Awards ceremony will be held at the Houses of Parliament on 26 September 2006.

For further details, or to arrange an interview with Prix Galien judges Professor Sir Michael Rawlins (NICE) or Professor Parveen Kumar (BMA) please contact Sarah Beyrath at Right Angle Learning: Sarah.Beyrath@ralearning.com. Ph: 020 8834 1039 or 07958672239

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK on course for 50,000 COVID-19 cases a day by mid-October

UK on course for 50,000 COVID-19 cases a day by mid-October

The UK could see 50,000 COVID-19 cases per day by mid-October, with the epidemic...

Stricter short-term COVID-19 measures needed to avoid second national lockdown, BMA warns

Stricter short-term COVID-19 measures needed to avoid second national lockdown, BMA warns

COVID-19 infection rates will ‘soar’ and the NHS will ‘once again be crippled’ if...

Practices handed one-month opt-out window as revamped network DES unveiled

Practices handed one-month opt-out window as revamped network DES unveiled

NHS England has unveiled a revamped DES package for 2020/21 confirming new targets,...

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered a huge increase in face-to-face appointments in the week before NHS...

RCGP facing legal action over stance on assisted dying

RCGP facing legal action over stance on assisted dying

The RCGP is facing legal action over its decision to remain opposed to assisted dying...

Medeconomics Live aims to help practices thrive under the new GP contract

Medeconomics Live aims to help practices thrive under the new GP contract

The one-day, virtual Medeconomics Live conference aims to provide practices with...